LIBERTY LATIN AMERIC-CL C (LILAK) Stock Fundamental Analysis

NASDAQ:LILAK • BMG9001E1286

8.1 USD
+0.02 (+0.25%)
At close: Feb 20, 2026
8.1 USD
0 (0%)
After Hours: 2/20/2026, 8:00:01 PM
Fundamental Rating

2

LILAK gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 37 industry peers in the Diversified Telecommunication Services industry. LILAK has a bad profitability rating. Also its financial health evaluation is rather negative. LILAK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • LILAK had negative earnings in the past year.
  • In the past year LILAK had a positive cash flow from operations.
  • LILAK had negative earnings in each of the past 5 years.
  • LILAK had a positive operating cash flow in 4 of the past 5 years.
LILAK Yearly Net Income VS EBIT VS OCF VS FCFLILAK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

  • LILAK has a worse Return On Assets (-6.10%) than 70.27% of its industry peers.
  • LILAK has a Return On Equity of -116.78%. This is amonst the worse of the industry: LILAK underperforms 86.49% of its industry peers.
  • LILAK has a better Return On Invested Capital (5.38%) than 62.16% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for LILAK is below the industry average of 6.69%.
  • The last Return On Invested Capital (5.38%) for LILAK is above the 3 year average (4.30%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -6.1%
ROE -116.78%
ROIC 5.38%
ROA(3y)-2.32%
ROA(5y)-2.88%
ROE(3y)-23.98%
ROE(5y)-23.6%
ROIC(3y)4.3%
ROIC(5y)3.96%
LILAK Yearly ROA, ROE, ROICLILAK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

  • With a Operating Margin value of 15.71%, LILAK perfoms like the industry average, outperforming 59.46% of the companies in the same industry.
  • LILAK's Operating Margin has declined in the last couple of years.
  • The Gross Margin of LILAK (77.79%) is better than 94.59% of its industry peers.
  • In the last couple of years the Gross Margin of LILAK has remained more or less at the same level.
Industry RankSector Rank
OM 15.71%
PM (TTM) N/A
GM 77.79%
OM growth 3Y-7.22%
OM growth 5Y-4.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y0.13%
LILAK Yearly Profit, Operating, Gross MarginsLILAK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LILAK is destroying value.
  • There is no outstanding debt for LILAK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LILAK Yearly Shares OutstandingLILAK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
LILAK Yearly Total Debt VS Total AssetsLILAK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 0.19, we must say that LILAK is in the distress zone and has some risk of bankruptcy.
  • LILAK has a Altman-Z score of 0.19. This is amonst the worse of the industry: LILAK underperforms 81.08% of its industry peers.
  • LILAK has a debt to FCF ratio of 37.52. This is a negative value and a sign of low solvency as LILAK would need 37.52 years to pay back of all of its debts.
  • LILAK has a worse Debt to FCF ratio (37.52) than 62.16% of its industry peers.
  • LILAK has a Debt/Equity ratio of 12.45. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 12.45, LILAK is doing worse than 83.78% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 12.45
Debt/FCF 37.52
Altman-Z 0.19
ROIC/WACC0.74
WACC7.24%
LILAK Yearly LT Debt VS Equity VS FCFLILAK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 1.14 indicates that LILAK should not have too much problems paying its short term obligations.
  • The Current ratio of LILAK (1.14) is comparable to the rest of the industry.
  • LILAK has a Quick Ratio of 1.14. This is a normal value and indicates that LILAK is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.14, LILAK perfoms like the industry average, outperforming 51.35% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1.14
LILAK Yearly Current Assets VS Current LiabilitesLILAK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 8.38% over the past year.
EPS 1Y (TTM)8.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.8%

3.2 Future

  • The Earnings Per Share is expected to grow by 37.33% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, LILAK will show a small growth in Revenue. The Revenue will grow by 2.70% on average per year.
EPS Next Y95.89%
EPS Next 2Y46.29%
EPS Next 3Y37.33%
EPS Next 5YN/A
Revenue Next Year-2.57%
Revenue Next 2Y2.44%
Revenue Next 3Y2.88%
Revenue Next 5Y2.7%

3.3 Evolution

LILAK Yearly Revenue VS EstimatesLILAK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
LILAK Yearly EPS VS EstimatesLILAK Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 -2 -3

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for LILAK. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LILAK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LILAK Price Earnings VS Forward Price EarningsLILAK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, LILAK is valued a bit cheaper than the industry average as 78.38% of the companies are valued more expensively.
  • LILAK's Price/Free Cash Flow ratio is rather cheap when compared to the industry. LILAK is cheaper than 89.19% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.34
EV/EBITDA 5.83
LILAK Per share dataLILAK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

  • LILAK's earnings are expected to grow with 37.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.29%
EPS Next 3Y37.33%

0

5. Dividend

5.1 Amount

  • No dividends for LILAK!.
Industry RankSector Rank
Dividend Yield 0%

LIBERTY LATIN AMERIC-CL C

NASDAQ:LILAK (2/20/2026, 8:00:01 PM)

After market: 8.1 0 (0%)

8.1

+0.02 (+0.25%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)02-18
Earnings (Next)05-05
Inst Owners67.85%
Inst Owner Change-0.73%
Ins Owners11.62%
Ins Owner ChangeN/A
Market Cap1.62B
Revenue(TTM)N/A
Net Income(TTM)-734.40M
Analysts77.78
Price Target10.03 (23.83%)
Short Float %15.44%
Short Ratio5.39
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2194.29%
Min EPS beat(2)-4518.74%
Max EPS beat(2)130.17%
EPS beat(4)1
Avg EPS beat(4)-1695.82%
Min EPS beat(4)-4518.74%
Max EPS beat(4)130.17%
EPS beat(8)2
Avg EPS beat(8)-5925.87%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.81%
Min Revenue beat(2)-3.49%
Max Revenue beat(2)-0.13%
Revenue beat(4)0
Avg Revenue beat(4)-2.19%
Min Revenue beat(4)-4.03%
Max Revenue beat(4)-0.13%
Revenue beat(8)0
Avg Revenue beat(8)-2.9%
Revenue beat(12)0
Avg Revenue beat(12)-3.21%
Revenue beat(16)1
Avg Revenue beat(16)-2.53%
PT rev (1m)0.4%
PT rev (3m)7.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-900%
EPS NY rev (1m)-1.74%
EPS NY rev (3m)-0.75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.37
P/FCF 7.34
P/OCF 2.18
P/B 2.58
P/tB N/A
EV/EBITDA 5.83
EPS(TTM)-3.06
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)1.1
FCFY13.62%
OCF(TTM)3.71
OCFY45.82%
SpS22.15
BVpS3.14
TBVpS-20.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.1%
ROE -116.78%
ROCE 6.81%
ROIC 5.38%
ROICexc 5.71%
ROICexgc 11.14%
OM 15.71%
PM (TTM) N/A
GM 77.79%
FCFM 4.98%
ROA(3y)-2.32%
ROA(5y)-2.88%
ROE(3y)-23.98%
ROE(5y)-23.6%
ROIC(3y)4.3%
ROIC(5y)3.96%
ROICexc(3y)4.63%
ROICexc(5y)4.26%
ROICexgc(3y)9.72%
ROICexgc(5y)8.98%
ROCE(3y)5.45%
ROCE(5y)5.02%
ROICexgc growth 3Y-0.27%
ROICexgc growth 5Y1.35%
ROICexc growth 3Y-1.91%
ROICexc growth 5Y1.9%
OM growth 3Y-7.22%
OM growth 5Y-4.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y0.13%
F-Score5
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 12.45
Debt/FCF 37.52
Debt/EBITDA 4.91
Cap/Depr 58.1%
Cap/Sales 11.77%
Interest Coverage 1.23
Cash Conversion 46.56%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 1.14
Altman-Z 0.19
F-Score5
WACC7.24%
ROIC/WACC0.74
Cap/Depr(3y)62.1%
Cap/Depr(5y)64.9%
Cap/Sales(3y)12.93%
Cap/Sales(5y)13.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70%
EPS Next Y95.89%
EPS Next 2Y46.29%
EPS Next 3Y37.33%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.8%
Revenue Next Year-2.57%
Revenue Next 2Y2.44%
Revenue Next 3Y2.88%
Revenue Next 5Y2.7%
EBIT growth 1Y40.47%
EBIT growth 3Y-9.58%
EBIT growth 5Y-1.84%
EBIT Next Year759.61%
EBIT Next 3Y119%
EBIT Next 5Y83.24%
FCF growth 1Y-25.99%
FCF growth 3Y-8.29%
FCF growth 5Y-8.09%
OCF growth 1Y-15.95%
OCF growth 3Y-9.38%
OCF growth 5Y-3.81%

LIBERTY LATIN AMERIC-CL C / LILAK FAQ

Can you provide the ChartMill fundamental rating for LIBERTY LATIN AMERIC-CL C?

ChartMill assigns a fundamental rating of 2 / 10 to LILAK.


What is the valuation status for LILAK stock?

ChartMill assigns a valuation rating of 3 / 10 to LIBERTY LATIN AMERIC-CL C (LILAK). This can be considered as Overvalued.


How profitable is LIBERTY LATIN AMERIC-CL C (LILAK) stock?

LIBERTY LATIN AMERIC-CL C (LILAK) has a profitability rating of 3 / 10.


Is the dividend of LIBERTY LATIN AMERIC-CL C sustainable?

The dividend rating of LIBERTY LATIN AMERIC-CL C (LILAK) is 0 / 10 and the dividend payout ratio is 0%.